Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Manufacturing: SOP for Controlling Particle Contamination in Aseptic Areas – V 2.0

Posted on By

Manufacturing: SOP for Controlling Particle Contamination in Aseptic Areas – V 2.0

Standard Operating Procedure for Controlling Particle Contamination in Aseptic Areas


Department Manufacturing
SOP No. SOP/MFG/176/2025
Supersedes SOP/MFG/176/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 25/06/2025
Review Date 24/06/2026

1. Purpose

This SOP establishes a standardized procedure for preventing and controlling particle contamination in aseptic areas. The goal is to ensure product sterility and compliance with cGMP and regulatory standards, including WHO, EU GMP Annex 1, and US FDA guidance.

2. Scope

This SOP applies to all Grade A and

Grade B aseptic environments used in sterile injectable manufacturing operations including filling, stoppering, lyophilization, and related processes.

3. Responsibilities

  • Production Personnel: Follow aseptic practices and gowning procedures strictly.
  • QA Officer: Perform routine particulate monitoring and review results.
  • Engineering Team: Maintain HVAC systems and ensure HEPA filter integrity.
  • Microbiology Analyst: Conduct environmental particulate monitoring using calibrated particle counters.

4. Accountability

The Head of Manufacturing is accountable for the implementation and enforcement of contamination control strategies in aseptic areas, and ensuring all deviations are addressed and investigated.

See also  Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intraosseous Injections - V 2.0

5. Procedure

5.1 Cleanroom Gowning Practices

  1. Personnel shall be trained and qualified in aseptic gowning before entry into cleanrooms.
  2. Gowning shall be done in a stepwise fashion through classified change rooms (Grade D to Grade B).
  3. Cleanroom garments must be sterile, non-linting, and free from damage. Gloves must be powder-free and sterile.
  4. Any breach in gown integrity must be reported immediately and rectified.

5.2 Housekeeping and Cleaning Controls

  1. Use only approved lint-free wipes and mops in the aseptic area.
  2. Follow predefined cleaning schedules for walls, floors, equipment surfaces, and ceilings.
  3. Clean Grade A surfaces at the beginning, during, and after operations using approved disinfectants.
  4. Replace mop heads and wipes frequently to prevent shedding or particle dispersal.

5.3 Environmental Monitoring for Non-Viable Particles

  1. Use calibrated laser particle counters to monitor 0.5 µm and 5.0 µm particle sizes.
  2. Perform monitoring at:
    • Start and end of each filling session
    • During critical operations
    • After any maintenance activity
  3. Record and evaluate results using alert and action limits defined per ISO 14644-1 standard.
  4. Document monitoring data in Annexure-1.

5.4 Equipment and Material Transfer

  1. Ensure materials and components entering aseptic zones are sterile or sterilized by validated methods.
  2. Use airlocks with interlocking doors and material pass-boxes for transfer.
  3. Perform particle decontamination by wiping with sterile 70% IPA prior to entry.
See also  Sterile Injectable Manufacturing: SOP for Batch Verification of Dispensed Materials - V 2.0

5.5 Maintenance of HVAC and HEPA Filters

  1. Maintain air change rates as per classified area requirements (e.g., >240 ACH in Grade A).
  2. Ensure unidirectional airflow is maintained over critical zones at ≥0.45 m/s ± 20%.
  3. HEPA filters must be integrity tested semi-annually using PAO or DOP test methods.
  4. Record and report test results in Annexure-2.

5.6 Identification and Investigation of Particle Sources

  1. If particle counts exceed action limits:
    • Stop aseptic operations and notify QA immediately.
    • Initiate deviation report and conduct root cause analysis.
    • Possible sources include: garment damage, glove shedding, equipment malfunction, or filter leak.
  2. Document findings in Annexure-3.

5.7 Training and Qualification

  1. All personnel shall undergo initial and periodic refresher training in:
    • Aseptic behavior and movements
    • Gowning procedures
    • Contamination risk reduction
  2. Maintain training records in Annexure-4.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • HEPA: High Efficiency Particulate Air
  • ACH: Air Changes per Hour
  • IPA: Isopropyl Alcohol
  • QA: Quality Assurance
  • HVAC: Heating, Ventilation and Air Conditioning

7. Documents

  1. Non-Viable Particle Monitoring Log – Annexure-1
  2. HEPA Filter Integrity Test Report – Annexure-2
  3. Particle Source Investigation Log – Annexure-3
  4. Aseptic Area Training Log – Annexure-4
See also  Sterile Injectable Manufacturing: SOP for Inspection of Injectable Solutions before Filling - V 2.0

8. References

  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • ISO 14644-1: Classification of air cleanliness
  • WHO TRS 961 Annex 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Non-Viable Particle Monitoring Log

Date Area 0.5µm Count 5.0µm Count Operator
24/06/2025 Filling Line A 215 1 Rajesh Kumar

Annexure-2: HEPA Filter Integrity Test Report

Filter ID Location Test Date Result Tested By
HEPA-07 Grade A Zone 22/06/2025 Pass Sunita Reddy

Annexure-3: Particle Source Investigation Log

Date Deviation Probable Source Corrective Action Approved By
20/06/2025 Particle >5µm Detected Garment Fiber Re-trained operator and replaced gown QA Manager

Annexure-4: Aseptic Area Training Log

Employee Name Training Date Trainer Topics Covered Status
Ajay Verma 10/06/2025 QA Officer Aseptic Practices Completed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial issue New SOP QA Head
24/06/2025 2.0 Updated monitoring points and HEPA test section Annual review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Handling Returned Gel Products – V 2.0
Next Post: Analytical Method Development: SOP for Osmolarity Testing of Ophthalmic Solutions – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version